V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002536 | 210006061 | null | 82 | Palliative (P) | null | 2016-08-20 | Docetaxel | 02 | N | DOCETAXEL | 100364931 |
| 210002537 | 210006062 | 1.72 | 83.6 | Adjuvant (A) | 2019-06-05 | 2019-06-05 | Docetaxel | 02 | N | DOCETAXEL | 100739547 |
| 210002538 | 210006063 | 1.58 | 78.3 | Palliative (P) | 2016-08-10 | 2016-08-12 | TRASTUZUMAB | null | N | TRASTUZUMAB | 100234573 |
| 210002539 | 210006064 | 1.53 | 73.8 | Adjuvant (A) | 2018-09-30 | 2018-10-15 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100210041 |
| 210002540 | 210006065 | null | null | null | 2016-01-05 | 2016-04-09 | Trastuzumab Subcutaneous | null | null | TRASTUZUMAB | 100611363 |
| 210002542 | 210006066 | 1.57 | 55.7 | Adjuvant (A) | 2018-11-13 | 2018-11-23 | PACLITAXEL | 02 | N | PACLITAXEL | 100065216 |
| 210002545 | 210006068 | null | null | null | 2018-11-28 | 2019-03-28 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100884492 |
| 210002548 | 210006070 | null | 114.5 | null | 2017-07-19 | 2017-08-23 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100293159 |
| 210002550 | 210006071 | 1.61 | 106.4 | Adjuvant (A) | 2018-12-24 | 2018-12-24 | Docetaxel | 02 | N | DOCETAXEL | 100117369 |
| 210002553 | 210006073 | 1.47 | 60.7 | Adjuvant (A) | 2018-09-16 | 2018-10-15 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100185005 |
| 210002556 | 210006076 | 1.59 | 107.2 | Adjuvant (A) | null | 2018-09-25 | Docetaxel | null | N | DOCETAXEL | 100056504 |
| 210002561 | 210006078 | 1.57 | 97.9 | Neo-adjuvant (N) | 2016-07-12 | 2016-07-14 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100538153 |
| 210002563 | 210006079 | 1.6 | null | Adjuvant (A) | 2017-07-07 | 2017-08-12 | PACLITAXEL | null | null | PACLITAXEL | 101302448 |
| 210002566 | 210006082 | 1.54 | 59.8 | Adjuvant (A) | 2016-04-26 | 2016-05-09 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101481891 |
| 210002567 | 210006083 | 1.61 | 68.55 | Adjuvant (A) | 2017-01-08 | 2017-01-23 | PACLITAXEL | 02 | Y | PACLITAXEL | 101682300 |
| 210002568 | 210006084 | 1.64 | 45.2 | null | null | 2017-02-11 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 101560712 |
| 210002569 | 210006085 | 1.62 | 108.9 | Palliative (P) | 2017-01-28 | 2017-02-19 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101138140 |
| 210002570 | 210006086 | 1.63 | 67.9 | Adjuvant (A) | 2017-10-26 | 2017-10-26 | Docetaxel | 02 | N | DOCETAXEL | 100503940 |
| 210002571 | 210006087 | 1.56 | null | Adjuvant (A) | 2017-05-10 | 2017-05-23 | Docetaxel | null | N | DOCETAXEL | 100023673 |
| 210002572 | 210006088 | 1.62 | 69.4 | Palliative (P) | 2018-07-03 | 2018-07-18 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101158041 |
| 210002573 | 210006089 | 1.64 | 88.1 | Adjuvant (A) | 2021-07-09 | 2021-07-28 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101559597 |
| 210002574 | 210006090 | 1.79 | 65.3 | null | 2018-11-04 | 2018-11-20 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100868184 |
| 210002575 | 210006091 | 1.7 | 58.2 | Adjuvant (A) | 2016-06-20 | 2016-10-01 | Docetaxel | 02 | N | DOCETAXEL | 100539481 |
| 210002576 | 210006092 | 1.59 | 82.2 | Adjuvant (A) | 2017-10-05 | 2017-10-20 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100815437 |
| 210002577 | 210006093 | null | 95.9 | null | null | 2016-11-28 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101158272 |
| 210002578 | 210006094 | null | 69 | Adjuvant (A) | null | 2018-12-07 | Docetaxel | 02 | N | DOCETAXEL | 100134272 |
| 210002579 | 210006095 | 1.64 | 68 | Adjuvant (A) | 2019-03-22 | 2019-03-30 | Docetaxel | 02 | N | DOCETAXEL | 101193499 |
| 210002580 | 210006096 | null | null | null | 2018-05-09 | 2018-05-27 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100860263 |
| 210002583 | 210006099 | 1.59 | 64.4 | Adjuvant (A) | 2016-04-19 | 2016-05-31 | TRASTUZUMAB | null | N | TRASTUZUMAB | 100273667 |
| 210002584 | 210006100 | 1.67 | 86.5 | Adjuvant (A) | 2016-05-16 | 2016-05-16 | Docetaxel | 02 | N | DOCETAXEL | 100119633 |
| 210002585 | 210006101 | 1.66 | 87 | Adjuvant (A) | 2019-10-05 | 2019-10-20 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100680230 |
| 210002587 | 210006102 | 1.63 | 0 | Neo-adjuvant (N) | 2018-06-01 | 2018-06-12 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100698588 |
| 210002590 | 210006104 | null | 0 | null | null | 2019-08-12 | Docetaxel | 02 | null | DOCETAXEL | 101244281 |
| 210002591 | 210006105 | 1.65 | 65 | Adjuvant (A) | 2016-05-03 | 2016-05-19 | Docetaxel | null | N | DOCETAXEL | 100810001 |
| 210002594 | 210006107 | 1.63 | 71.9 | Adjuvant (A) | 2017-09-19 | 2017-09-30 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101692606 |
| 210002596 | 210006109 | null | 66.4 | null | 2018-10-10 | 2018-10-26 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101122396 |
| 210002598 | 210006111 | 1.66 | 77.8 | null | 2019-04-19 | 2019-05-07 | PACLITAXEL | 02 | N | PACLITAXEL | 100537520 |
| 210002599 | 210006112 | 1.74 | 88.9 | Adjuvant (A) | 2017-10-05 | 2017-10-25 | Docetaxel | 02 | N | DOCETAXEL | 101220811 |
| 210002600 | 210006113 | 1.69 | 89 | Palliative (P) | 2019-02-17 | 2019-03-11 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101380924 |
| 210002601 | 210006114 | 1.63 | 112.4 | Adjuvant (A) | 2018-07-24 | 2018-08-01 | EC | 01 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101074828 |
| 210002603 | 210006116 | 1.54 | 59.5 | Neo-adjuvant (N) | null | 2018-07-07 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100301316 |
| 210002604 | 210006117 | 1.68 | 83.2 | Palliative (P) | 2018-03-02 | 2018-08-09 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100550872 |
| 210002605 | 210006118 | 1.52 | 72 | Adjuvant (A) | null | 2016-02-09 | Docetaxel | 02 | N | DOCETAXEL | 100062568 |
| 210002607 | 210006119 | 1.63 | 50.5 | Neo-adjuvant (N) | 2018-09-11 | 2018-09-19 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101042288 |
| 210002609 | 210006121 | 1.61 | 72.85 | Adjuvant (A) | 2016-10-19 | 2016-10-24 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100649439 |
| 210002610 | 210006122 | 1.58 | 110.3 | Neo-adjuvant (N) | null | 2019-07-04 | Docetaxel | null | N | DOCETAXEL | 101722795 |
| 210002611 | 210006123 | 1.57 | null | Adjuvant (A) | 2020-01-29 | 2020-02-14 | Paclitaxel (2 or 3 weekly) | 02 | N | PACLITAXEL | 101516640 |
| 210002612 | 210006124 | null | null | null | 2018-04-11 | 2018-05-02 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100437174 |
| 210002613 | 210006125 | 1.63 | 81.5 | Adjuvant (A) | 2018-05-10 | 2018-05-17 | Docetaxel | null | N | DOCETAXEL | 100176658 |
| 210002614 | 210006126 | 1.6 | 71.1 | Palliative (P) | 2016-08-26 | 2016-08-26 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101380607 |